Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

EMEA will not approve Cerepro at this time

May 2, 2007

Acropolis reports on PA-105, an antiangiogenic agent with antiprostate cancer activity

May 2, 2007

SciClone acquires rights in U.S. and Canada to RP-101

May 2, 2007

Kyowa Hakko Kogyo licenses Japanese and Asian rights to ARQ-197

May 2, 2007

Novel Amgen c-Met inhibitors reported to be active against multiple mutations

April 30, 2007

CHMP hands down negative opinion on Genasense for melanoma

April 30, 2007

Vascular disrupting activity of MPC-6827 alone or in combination with carboplatin

April 30, 2007

New somatostatin receptor ligand shows antitumor activity in vivo

April 30, 2007

Novel c-Met inhibitor presented at the AACR meeting

April 30, 2007

Preclinical profile of the c-Met inhibitor ARQ-197 reported by ArQule

April 30, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
mRNA flu vaccine can activate broad germinal center response
BioWorld
On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...